Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Truven Health is a healthcare data and analytics business best known for real-world data, claims and benchmarking assets, and clinical decision support products used by payers, employers, providers, government agencies, and life sciences companies. The business originated as Truven Health Analytics and was acquired by IBM in 2016 for approximately $2.6 billion, later becoming part of IBM Watson Health and then Merative. Today the Truven brand continues within Merative, where it supports healthcare analytics, price transparency, employer and payer decision support, and life sciences research through products such as MarketScan and related analytics offerings. Unlike a drug developer, Truven is primarily a commercial healthcare information and software company rather than a therapeutics company. Its core value lies in curated healthcare datasets, benchmarking methodologies, and analytics used for care management, health economics, outcomes research, and operational performance improvement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Truven Health.